Trade AstraZeneca ^AZN

Traders Buy High Volume of Call Options on AstraZeneca (NASDAQ:AZN)

Crumly & Associates Inc. Increases Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Bank of Stockton Has $307,000 Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca | Morningstar

GSK (GSK) Faces Challenges Amid Patent Expiry and Investor Pressure

Lost Money on AstraZeneca PLC(AZN)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky | Morningstar

Atria Wealth Solutions Inc. Acquires 6,970 Shares of AstraZeneca PLC (NASDAQ:AZN)

Signs of relief for AstraZeneca as China courts foreign investors | South China Morning Post

Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial

Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay

AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal

Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile

AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds

FDA posts observations from AstraZeneca site inspection | Markets Insider

DEADLINE ALERT for CPRI, AZN, RIG: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions | Morningstar

JPMorgan Chase & Co. Reaffirms Overweight Rating for AstraZeneca (LON:AZN)

Bernstein Reaffirms Their Buy Rating on AstraZeneca (AZN) | Markets Insider

FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million | The Manila Times

Meitav Investment House Ltd. Raises Stake in AstraZeneca PLC (NASDAQ:AZN)

FibroGen Sells China Subsidiary To AstraZeneca For $160 Mln, Stock Up

Truist Financial Corp Has $15.98 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

Catalyst Capital Advisors LLC Has $29,000 Holdings in AstraZeneca PLC (NASDAQ:AZN)

Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus - February 20, 2025 - Zacks.com

Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial

No OS Boost With Palbociclib and Endocrine Therapy in Premenopausal Breast Cancer

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

Temporal evolution of breast cancer brain metastases treatments and outcomes

AstraZeneca Rises Almost 9% in a Month: How to Play the Stock - February 20, 2025 - Zacks.com

AstraZeneca's (AZN) Overweight Rating Reiterated at JPMorgan Chase & Co.

Could this Nvidia-backed growth stock be a millionaire-maker at $10?

Principal Securities Inc. Has $1.83 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Holdings Raised by Allspring Global Investments Holdings LLC

PARP Inhibitors Market to Hit US$ 6.64 Billion by 2031, Fueled by Rising Cancer Incidence

In the clinic for Feb. 19, 2025 | BioWorld

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)

Human-correlated genetic models identify precision therapy for liver cancer

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN | Morningstar

AstraZeneca (LON:AZN) Has Announced That It Will Be Increasing Its Dividend To $1.68

JFS Wealth Advisors LLC Boosts Stake in AstraZeneca PLC (NASDAQ:AZN)

CIBC Asset Management Inc Has $15.37 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)

Americana Partners LLC Acquires 14,309 Shares of AstraZeneca PLC (NASDAQ:AZN)

25,632 Shares in AstraZeneca PLC (NASDAQ:AZN) Bought by Strategic Financial Concepts LLC

PARP Inhibitors Market: Key Insights, Growth Factors, and Strategic Developments in the Oncology Sector

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy

How DHL Helped AstraZeneca Decarbonise Air Freight With SAF

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by NTV Asset Management LLC

AlphaCentric Advisors LLC Purchases Shares of 31,685 AstraZeneca PLC (NASDAQ:AZN)

GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly sale

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Moser Wealth Advisors LLC